Top Markets
Coin of the day
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
Peringkat dalam Saham #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
Harga Saham
$0.0001
Terakhir disinkronkan: 2025-06-02
Kapitalisasi Pasar
$3.82K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CN
Perdagangan China BCT Pharmacy Group, Inc. (CNBI)

Kategori

Harga CNBI dengan kapitalisasi pasar B
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
CNBI
$0.0001
Kapitalisasi pasar dari China BCT Pharmacy Group, Inc.(CNBI)
Kapitalisasi Pasar: $3.82K
Per August 2026, China BCT Pharmacy Group, Inc. memiliki kapitalisasi pasar sebesar $3.82K. Ini menjadikan China BCT Pharmacy Group, Inc. sebagai perusahaan 42162nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar China BCT Pharmacy Group, Inc. dari 2010 hingga 2026
CNBI dibandingkan dengan 5 teratas stocks paling populer
Harga CNBI Aset B Pasar B Hasil
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$141,094 $3.82K
$5.383T +141,094,292,751.11%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$115,934 $3.82K
$4.423T +115,934,159,328.25%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$109,041 $3.82K
$4.160T +109,040,531,695.15%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$96,013.21 $3.82K
$3.663T +96,013,217,450.08%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$75,777.19 $3.82K
$2.891T +75,777,195,420.53%